Low-Grade Oncocytic Tumor of Kidney (CK7-Positive, CD117-Negative): Incidence in a single institutional experience with clinicopathological and molecular characteristics O Kravtsov, S Gupta, JC Cheville, WR Sukov, R Rowsey, ... Human pathology 114, 9-18, 2021 | 42 | 2021 |
PTEN loss and p27 loss differ among morphologic patterns of prostate cancer, including cribriform S Ronen, DW Abbott, O Kravtsov, A Abdelkader, Y Xu, A Banerjee, ... Human Pathology 65, 85-91, 2017 | 39 | 2017 |
Microglandular adenosis and associated invasive carcinoma O Kravtsov, JM Jorns Archives of Pathology & Laboratory Medicine 144 (1), 42-46, 2020 | 13 | 2020 |
Myoepithelioma of soft tissue: a cytological-pathological correlation with literature review O Kravtsov, J Chang, D Hackbarth, T Giorgadze Annals of Diagnostic Pathology 27, 14-17, 2017 | 11 | 2017 |
Growth and differentiation factor 15 and NF‐κB expression in benign prostatic biopsies and risk of subsequent prostate cancer detection BA Rybicki, SM Sadasivan, Y Chen, O Kravtsov, W Palangmonthip, ... Cancer Medicine 10 (9), 3013-3025, 2021 | 10 | 2021 |
Secretory carcinoma of the parotid with adenoid cystic carcinoma cytological pattern: A cytological-pathological correlation with literature review O Kravtsov, B Hunt, J Peterson, L Carrillo, P Bonneau, T Giorgadze Annals of Diagnostic Pathology 33, 58-61, 2018 | 8 | 2018 |
KIF3B protein expression loss correlates with metastatic ability of prostate cancer O Kravtsov, CP Hartley, EM Compérat, KA Iczkowski American Journal of Clinical and Experimental Urology 7 (3), 178, 2019 | 6 | 2019 |
Benign vascular lesions and angiolipomas of the breast: Radiologic-pathologic correlation O Kravtsov, K Techawatanaset, S Cherian, JM Jorns The breast journal 26 (9), 1906-1908, 2020 | 4 | 2020 |
Proteinaceous lymphadenopathy in a young patient with history of classical Hodgkin lymphoma: a case report with literature review O Kravtsov, R Jaffe, G Gheorghe International Journal of Surgical Pathology 27 (2), 176-180, 2019 | 4 | 2019 |
Testicular juvenile granulosa cell tumors demonstrate recurrent loss of chromosome 10 and absence of molecular alterations described in ovarian counterparts K Collins, LM Sholl, SO Vargas, KM Cornejo, O Kravtsov, BC Dickson, ... Modern Pathology 36 (6), 100142, 2023 | 3 | 2023 |
Utility of PD-L1 testing on non-small cell lung cancer cytology specimens: an institutional experience with interobserver variability analysis O Kravtsov, CP Hartley, Y Sheinin, BC Hunt, JC Felix, T Giorgadze Annals of Diagnostic Pathology 48, 151602, 2020 | 3 | 2020 |
Racial Disparities in Expression of GDF15 and NFκB in Prostate Cancer and Benign Prostatic Epithelium K Iczkowski, O Kravtsov, S Sadasivan, W Palangmonthip, Y Chen, ... Cancer Health Disparities, 2020 | 3 | 2020 |
Clear cell mesotheliomas with inactivating VHL mutations and near‐haploid genomic features M Michal, O Kravtsov, JS Ross, D Skanderová, P Martínek, E Mosaieby, ... Genes, Chromosomes and Cancer 62 (5), 267-274, 2023 | 2 | 2023 |
Low-grade oncocytic tumor of kidney (CK7-positive, CD117-negative): a single institutional experience with incidence and clinicopathological characteristics O Kravtsov, S Gupta, J Cheville, LH Hernandez, R Jimenez LABORATORY INVESTIGATION 100 (SUPPL 1), 917-918, 2020 | 2 | 2020 |
Landscape of fibroblast growth factor receptor (FGFR) genomic alterations (GA) in urothelial bladder cancer (UBC). M Bou Zerdan, G Bratslavsky, JM Jacob, RSP Huang, O Kravtsov, ... Journal of Clinical Oncology 40 (16_suppl), 4568-4568, 2022 | 1 | 2022 |
Association of RB1 mutational status with overall genomic landscape in neuroendocrine prostate cancer (NEPC). P Grivas, G Bratslavsky, JM Jacob, O Kravtsov, A Necchi, PE Spiess, ... Journal of Clinical Oncology 40 (16_suppl), 5063-5063, 2022 | 1 | 2022 |
PTEN and p27 Loss Differ Among Morphologic Patterns of Prostate Cancer DW Abbott, S Ronen, A Abdelkader, A Banerjee, Y Xu, O Kravtsov, ... LABORATORY INVESTIGATION 97, 210A-210A, 2017 | 1 | 2017 |
The 1000 Mitoses Project: A Consensus-Based International Collaborative Study on Mitotic Figures Classification S Lin, C Tran, E Bandari, T Romagnoli, Y Li, M Chu, AS Amirthakatesan, ... International Journal of Surgical Pathology, 10668969241234321, 2024 | | 2024 |
Impact of PD-L1 expression on conventional urothelial bladder carcinoma (UCB) genomic alteration (GA) profile. A Necchi, P Grivas, PE Spiess, G Bratslavsky, JM Jacob, O Kravtsov, ... Journal of Clinical Oncology 40 (16_suppl), e16535-e16535, 2022 | | 2022 |
Comprehensive genomic profiling (CGP) of chromophobe renal cell carcinoma (chrRCC) compared with non-chromophobe RCC (nonchrRCC): Impact of FLCN genomic alteration (GA) status. G Bratslavsky, A Necchi, P Grivas, JM Jacob, O Kravtsov, RSP Huang, ... Journal of Clinical Oncology 40 (16_suppl), 4550-4550, 2022 | | 2022 |